Dr. GSK Velu Sets Up Two Funds Worth $175 MN

SUMMARY

Investment Will Be Done In Healthcare Services, Consumer-led Companies & Enterprise Technology

Trivitron healthcare founder and Healthcare entrepreneur, GSK Velu, has set up two investment vehicles to invest in healthcare services, consumer- led companies and enterprise technology, reports ET.

The two funds have been segregated as a $100 Mn venture capital fund Stakeboat Capital and a family office with a corpus of $75 Mn.

The development has come after Velu exited the diagnostic chain Metropolis Healthcare, selling his 37% stake to leading private equity firm Carlyle, for $134 Mn (INR 900 Cr). He will be the non-executive chairman of Stakeboat. The fund will have two other general partners (GPs) including private equity veteran Kandaswamy Chandrashekhar and Athmanathan Ganesan.

The report mentioned that Velu will be the anchor investor in the new fund, contributing $20 Mn and the remaining $80 Mn will be raised from domestic family offices and large institutional funds.

In a statement, Velu said, “I have been working with PE investors for 11 years now. I know what the entrepreneurs are looking for and where PE can add most value. We will follow a promoter-friendly approach. Just like a stakeboat helps other boats navigate the race, our fund will steer entrepreneurs towards building sustainable and successful businesses.”

The fund is targeted towards the Series B investments in companies, who already have established cash flows and proven business models. Stakeboat will look at investments in domains like healthcare services, consumer- led companies and enterprise technology, while avoiding the consumer internet space.

Though the firm awaits SEBI’s approval, Kandaswamy Chandrashekhar said that they are actively examining deals. The funds will be first used from the anchor investment before external funds are raised from the market. It will look at a seven-year fund with an optional ‘plus two’ and an investment window of four-five years in each investee company.


Welcome to Flash Feed, your essential source for breaking news and innovation from around the web – bite-sized and updated all day.


You have reached your limit of free stories
Become An Inc42 Plus Member

Become a Startup Insider in 2024 with Inc42 Plus. Join our exclusive community of 10,000+ founders, investors & operators and stay ahead in India’s startup & business economy.

2 YEAR PLAN
₹19999
₹7999
₹333/Month
Unlock 60% OFF
Cancel Anytime
1 YEAR PLAN
₹9999
₹4999
₹416/Month
Unlock 50% OFF
Cancel Anytime
Already A Member?
Discover Startups & Business Models

Unleash your potential by exploring unlimited articles, trackers, and playbooks. Identify the hottest startup deals, supercharge your innovation projects, and stay updated with expert curation.

Dr. GSK Velu Sets Up Two Funds Worth $175 MN-Inc42 Media
How-To’s on Starting & Scaling Up

Empower yourself with comprehensive playbooks, expert analysis, and invaluable insights. Learn to validate ideas, acquire customers, secure funding, and navigate the journey to startup success.

Dr. GSK Velu Sets Up Two Funds Worth $175 MN-Inc42 Media
Identify Trends & New Markets

Access 75+ in-depth reports on frontier industries. Gain exclusive market intelligence, understand market landscapes, and decode emerging trends to make informed decisions.

Dr. GSK Velu Sets Up Two Funds Worth $175 MN-Inc42 Media
Track & Decode the Investment Landscape

Stay ahead with startup and funding trackers. Analyse investment strategies, profile successful investors, and keep track of upcoming funds, accelerators, and more.

Dr. GSK Velu Sets Up Two Funds Worth $175 MN-Inc42 Media
Dr. GSK Velu Sets Up Two Funds Worth $175 MN-Inc42 Media
You’re in Good company